Joseph’s background over the past 20 years covers the acquisition, development, and commercialization of medical devices, diagnostic products, and pharmaceuticals. He has founded and created successful exit strategies for 3 start-ups. Joseph has raised equity financing and negotiated industry-leading collaboration and licensing agreements with Roche, Novartis, Atrium, and Ubisoft.
medical science